Oral antidiabetic agents: current role in type 2 diabetes mellitus.
作者： Andrew J Krentz , Clifford J Bailey
DOI: 10.2165/00003495-200565030-00005
关键词:
摘要: … on treatment of hyperglycaemia in patients with type 2 diabetes. We consider both well established drugs … use be kept to a minimum in patients with overt coronary artery disease.[25] …
springer.com
luzimarteixeira.com.br 参考文章(163)
Ian W. Campbell, Antidiabetic drugs present and future: will improving insulin resistance benefit cardiovascular risk in type 2 diabetes mellitus? Drugs. ,vol. 60, pp. 1017- 1028 ,(2000) , 10.2165/00003495-200060050-00004
P. Sönksen, S. Barendse, J. D. Valentine, Clare Bradley, J. Speight, A. Bishop, N. Vaughan, Closing the audit loop with the Diabetes Clinic Satisfaction Questionnaire (DCSQ) : reducing sources of dissatisfaction and increasing clinician sensitivity to patients' views Diabetic Medicine. ,vol. 16, pp. 1- 15 ,(1999)
Testa I, Ambrosi F, Manfrini S, Gregorio F, Filipponi P, Is metformin safe enough for ageing type 2 diabetic patients Diabetes & Metabolism. ,vol. 22, pp. 43- 50 ,(1996)
A. Melander, Oral antidiabetic drugs: an overview. Diabetic Medicine. ,vol. 13, pp. 143- 147 ,(1996) , 10.1002/DME.1996.13.S6.143
Berger W, Incidence of severe sideeffects during therapy with sulfonylureas and biguanides. Hormone and metabolic research. Supplement series. ,vol. 15, pp. 111- 115 ,(1985)
Andr?? J Scheen, Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus? Drugs. ,vol. 63, pp. 933- 951 ,(2003) , 10.2165/00003495-200363100-00002
R??diger Landgraf, Meglitinide analogues in the treatment of type 2 diabetes mellitus. Drugs & Aging. ,vol. 17, pp. 411- 425 ,(2000) , 10.2165/00002512-200017050-00007
H.E. Lebovitz, A. Melander, Sulfonylureas: Basic Aspects and Clinical Uses International Textbook of Diabetes Mellitus. ,(2004) , 10.1002/0470862092.D0608
Baldwin, Clarke, Chenery, Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone. British Journal of Clinical Pharmacology. ,vol. 48, pp. 424- 432 ,(1999) , 10.1046/J.1365-2125.1999.00030.X
J. Vora, Type 2 Diabetes in Practice Diabetic Medicine. ,vol. 19, pp. 171- 171 ,(2002) , 10.1046/J.1464-5491.2002.00697.X